Tag: ReActiv8-A

ReActiv8’s clinically important disability, pain and quality-of-life improvements sustained at one-year

The disruption of lumbar multifidus muscle control is one factor involved in many cases of functional instability and chronic low back pain. Whilst targeted...

First commercial implantation of Mainstay Medical’s ReActiv8 performed in Germany

The first commercial implantation of Mainstay Medical’s ReActiv8 has taken place in Germany. The implantation was performed by Francis Kilian, orthopaedic and neurosurgeon at the...

Mainstay Medical applies for Australian marketing approval for ReActiv8

Mainstay Medical has applied for ReActiv8 to be admitted to the Australian Register of Therapeutic Goods (ARTG) which would allow for commercialisation in Australia. Mainstay’s...